Search results
Results from the WOW.Com Content Network
Oncology Today with Dr Neil Love: Special Edition — Presentations on Lung Cancer from Recent Major Conferences Featuring perspectives from Dr Tanios Bekaii-Saab and Dr Philip A Philip
Founded and led by medical oncologist Neil Love, MD, RTP has provided meaningful, relevant and unbiased educational perspectives for more than 30 years to meet the needs of oncology clinicians and positively impact the care of patients with cancer.
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice Featuring a discussion on the management of HR+ metastatic breast cancer with mutations in PI3K, AKT or PTEN with Drs Jhaveri and Rugo, moderated by Dr Neil Love.
For well over two decades, Research To Practice has been hosting live CME conferences and symposia designed specifically for oncology professionals.
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice Featuring a discussion on first-line therapy for HR-positive, HER2-negative metastatic breast cancer with Prof Bidard and Dr Kalinsky, moderated by Dr Neil Love.
The podcast service offered by Research To Practice (RTP) is a free service intended for private, non-commercial use. You may not edit, modify or redistribute any podcast content. RTP’s podcast is designed for educational purposes only and is not specifically designed to engage in rendering medical advice or professional services.
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice Featuring a discussion on the management of HR+ metastatic breast cancer with mutations in PI3K, AKT or PTEN with Drs Jhaveri and Rugo, moderated by Dr Neil Love.
This is Dr Neil Love from Research To Practice. Today, we focus on the management of ER-positive breast cancer and we have a great faculty, Dr Erica Mayer from the Dana-Farber Cancer Institute in Boston and Dr Ruth O'Regan from the University of Rochester in Rochester, New York.
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice Featuring a discussion of GI cancers after the 2024 ESMO annual congress and other conferences, with Drs Bekaii-Saab and Philip, moderated by Dr Neil Love.
Understand the mechanism of action of and available clinical research data with pacritinib in patients with MF and severe thrombocytopenia in order to optimally integrate this novel therapeutic approach into current MF management algorithms.